Variant report
Variant | esv3325918 |
---|---|
Chromosome Location | chr5:101385578-101388101 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532005644 | chr5:101385636-101385637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2045841 | chr5:101385698-101385699 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs3039993 | chr5:101385708-101385709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562270901 | chr5:101385747-101385748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148553824 | chr5:101385787-101385788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371717930 | chr5:101385793-101385794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs547632902 | chr5:101385822-101385823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565819600 | chr5:101385829-101385830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533278563 | chr5:101385841-101385842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs12054761 | chr5:101385881-101385882 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs569730082 | chr5:101385901-101385902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs199608971 | chr5:101385902-101385903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs193203288 | chr5:101385910-101385911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs151106869 | chr5:101385956-101385957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184145013 | chr5:101386017-101386018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534506138 | chr5:101386041-101386042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11242318 | chr5:101386075-101386076 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs140034968 | chr5:101386201-101386202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs374061493 | chr5:101386221-101386222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188529314 | chr5:101386251-101386252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368077126 | chr5:101386277-101386278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs77535087 | chr5:101386356-101386357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs28537404 | chr5:101386358-101386359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs28402848 | chr5:101386360-101386361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372481418 | chr5:101386366-101386367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs374639587 | chr5:101386372-101386373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189582656 | chr5:101386374-101386375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs368611412 | chr5:101386382-101386383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs28522468 | chr5:101386384-101386385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182001076 | chr5:101386386-101386387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs72129129 | chr5:101386395-101386396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs369238200 | chr5:101386403-101386404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs28688699 | chr5:101386404-101386405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372748290 | chr5:101386430-101386431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs28716905 | chr5:101386433-101386434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10045903 | chr5:101386436-101386437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs371519946 | chr5:101386456-101386457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs111531808 | chr5:101386457-101386458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs376988641 | chr5:101386459-101386460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10606966 | chr5:101386476-101386477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs11345981 | chr5:101386487-101386488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376499206 | chr5:101386493-101386494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs67122063 | chr5:101386503-101386504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs71593286 | chr5:101386512-101386513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375798817 | chr5:101386515-101386516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370949509 | chr5:101386523-101386524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs71586324 | chr5:101386545-101386546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374331050 | chr5:101386553-101386554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187659724 | chr5:101386575-101386576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs376128912 | chr5:101386583-101386584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:101384400-101386200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr5:101384400-101386200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr5:101384600-101386200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
4 | chr5:101384800-101385600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr5:101384800-101386000 | Enhancers | Fetal Intestine Large | intestine |
6 | chr5:101384800-101386000 | Enhancers | Fetal Intestine Small | intestine |
7 | chr5:101385200-101386200 | Enhancers | Primary hematopoietic stem cells | blood |
8 | chr5:101386200-101387400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr5:101387400-101387800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |